Pharmacopsychiatry, 0176-3679

Journal

Related Publications
  1. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients by K. Mori et al

    Aleman, A., Jan-2003, In : Pharmacopsychiatry. 36, 1, p. 43-4; author reply 44

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

  2. Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD

    Loonen, A. J. M. & Ivanova, S. A., Jul-2019, In : Pharmacopsychiatry. 52, 4, p. 203-204 2 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Lithium and Renal Impairment: A Review on a Still Hot Topic

    Nielsen, R. E., Kessing, L. V., Nolen, W. A. & Licht, R. W., Sep-2018, In : Pharmacopsychiatry. 51, 5, p. 200-205 6 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Cardiovascular risk factors in outpatients with bipolar disorder

    Klumpers, U. M. H., Boom, K., Janssen, F. M. G., Tulen, J. H. M. & Loonen, A. J. M., 1-Sep-2004, In : Pharmacopsychiatry. 37, 5, p. 211-216 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: a randomized triple blind placebo controlled study

    Fadai, F., Mousavi, B., Ashtari, Z., Ali beigi, N., Farhang, S., Hashempour, S., Shahhamzei, N. & Bathaie, S. Z., Jul-2014, In : Pharmacopsychiatry. 47, 4-5, p. 156-161 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (15) »

ID: 17491470